In re Bendectin Products Liability Litigation

Decision Date17 January 1990
Docket NumberMisc. No. 85-0996.
Citation732 F. Supp. 744
PartiesIn re BENDECTIN PRODUCTS LIABILITY LITIGATION.
CourtU.S. District Court — Western District of Michigan

Thomas Bleakley, Detroit, Mich., for plaintiffs.

Frank Woodside, III, Cincinnati, Ohio, for defendant.

ORDER

CARL B. RUBIN, Chief Judge.

This matter is before the Court on a motion for summary judgment pursuant to Fed.R.Civ.P. 56 filed by defendant Merrell Dow Pharmaceuticals, Inc. (Merrell Dow).1 Plaintiffs have filed an opposing memorandum and the defendant has subsequently replied.

Plaintiffs filed these products liability cases, now consolidated for trial before this Court, seeking damages for birth defects allegedly sustained by the minor plaintiffs as a result of their mothers' ingestion of the drug, Bendectin, during pregnancy. Merrell Dow, the manufacturer of Bendectin, moves for summary judgment of these cases on the theory that plaintiffs should be collaterally estopped from litigating the issue of whether Bendectin causes birth defects. Merrell Dow further argues that plaintiffs, as a matter of law, cannot demonstrate that a genuine issue of material fact exists as to the element of causation.

The summary judgment procedure under Federal Rule of Civil Procedure 56 is designed to secure a just, speedy, and inexpensive determination of any action. Celotex Corp. v. Catrett, 477 U.S. 317, 327, 106 S.Ct. 2548, 2554, 91 L.Ed.2d 265 (1986). However, Rule 56(c) permits the Court to grant summary judgment as a matter of law only after the moving party has identified as the basis of its motion "the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any" which demonstrate the absence of any genuine issue of material fact. Id. at 323, 106 S.Ct. at 2552. The party opposing a properly supported motion for summary judgment "may not rest upon mere allegations or denials of his pleading, but ... must set forth specific facts showing that there is a genuine issue for trial." Anderson v. Liberty Lobby, 477 U.S. 242, 248, 106 S.Ct. 2505, 2510, 91 L.Ed.2d 202 (1986) quoting First National Bank of Arizona v. Cities Service Co., 391 U.S. 253, 88 S.Ct. 1575, 20 L.Ed.2d 569 (1968). The evidence of the nonmovant is to be believed and all justifiable inferences are to be drawn in his favor. Anderson, supra 477 U.S. at 255, 106 S.Ct. at 2513 citing Adickes v. S.H. Kress & Co., 398 U.S. 144, 158, 90 S.Ct. 1598, 1609, 26 L.Ed.2d 142 (1970). The function of the court is not to weigh the evidence and determine the truth of the matter but to determine whether there is a genuine issue for trial. Anderson, supra 477 U.S. at 249, 106 S.Ct. at 2510. There is no genuine issue for trial unless there is sufficient evidence favoring the nonmoving party for a jury to return a verdict for that party. Anderson, supra at 249, 106 S.Ct. at 2510 citing Cities Service, 391 U.S. at 288-289, 88 S.Ct. at 1592-1593. If the evidence is merely colorable, Dombrowski v. Eastland, 387 U.S. 82, 87 S.Ct. 1425, 18 L.Ed.2d 577 (1967), or is not significantly probative, Cities Service, supra 391 U.S. at 290, 88 S.Ct. at 1593, judgment may be granted. Anderson, supra 477 U.S. at 249, 106 S.Ct. at 2510.

Merrell Dow contends that the principles of collateral estoppel bar plaintiffs from litigating their claims. Defendant asserts that the consolidated trial held before this Court in February and March, 1985 ("the MDL Common Issues Trial") provided plaintiffs with a fair opportunity to be heard on the issue of whether Bendectin causes birth defects.2 Merrell Dow further contends that based on the extensive history of the Bendectin litigation in which juries have returned verdicts in favor of Merrell Dow, or in the alternative, judges have granted defendant's motions for JNOV, relitigation of the causation issue is "fruitless". Since the vast majority of these trials have resulted in final verdicts or judgments for Merrell Dow, the defendant submits that the causation issue has been "exhaustively" litigated and "overwhelmingly" decided in the defendant's favor.

The Defensive Use Of Collateral Estoppel

The doctrine of collateral estoppel provides that an actual and necessary determination of an issue by a court of competent jurisdiction is conclusive in subsequent cases based upon a different cause of action but involving a party to the prior litigation. Parklane Hosiery Co. v. Shore, 439 U.S. 322, 326 n. 5, 99 S.Ct. 645, 649, n. 5, 58 L.Ed.2d 552 (1979). Federal law not state law governs the inquiry of whether a prior federal court judgment collaterally estops the adjudication of a subsequent federal diversity action involving identical issues. Cemer v. Marathon Oil Co., 583 F.2d 830, 831 (6th Cir.1978). Previously, the scope of collateral estoppel was limited by the doctrine of mutuality which precluded either party from using a prior judgment as an estoppel against the other unless both parties were bound by that judgment. Bigelow v. Old Dominion Copper Co., 225 U.S. 111, 127, 32 S.Ct. 641, 642, 56 L.Ed. 1009 (1912). The doctrine of mutuality has been eroded, Blonder-Tongue Laboratories, Inc. v. University of Illinois Foundation, 402 U.S. 313, 91 S.Ct. 1434, 28 L.Ed.2d 788 (1971), and a defendant may now preclude a nonparty to the previous suit from contesting an issue a plaintiff in the prior suit has already litigated and lost if the nonparty plaintiff has had a full and fair opportunity to be heard on the issue.3 Id. at 329, 91 S.Ct. at 1443.

Nonparties to a prior action have had a "full and fair opportunity" to litigate if they:

Assume control over litigation in which they have a direct financial or proprietary interest and then seek to redetermine issues previously resolved ... The persons for whose benefit and at whose direction a cause of action is litigated cannot be said to be "strangers to the cause ... One who prosecutes or defends a suit in the name of another to establish and protect his own right, or who assists in the prosecution or defense of an action in aid of some interest of his own ... is as much bound ... as he would be if he had been a party to the record."
Montana v. United States, 440 U.S. 147, 154, 99 S.Ct. 970, 974, 59 L.Ed.2d 210

(1979). The rule derived from the Supreme Court's examination of this issue is that a nonparty may be estopped if (1) he had a direct financial or proprietary interest in the prior litigation; and (2) he assumed control over the prior litigation. Virginia Hosp. Ass'n. v. Baliles, 830 F.2d 1308, 1312 (4th Cir.1987); see also Alman v. Danin, 801 F.2d 1, 4-5 (1st Cir.1986); 1B J. Moore, J. Lucas and T. Currier, Moore's Federal Practice ¶ 0.4116, at 445 (2d ed. 1984). The Montana rule ensures that the nonparty was afforded his right to due process. Hardy v. Johns-Manville Sales Corp., 681 F.2d 334, 338 (5th Cir.1982). If a nonparty had a direct financial or proprietary interest in the prior litigation, he had an incentive to litigate the issues raised in the previous suit fully. Virginia Hosp. Ass'n, supra at 1312. If the nonparty also had control over the prior litigation, he had the ability to ensure that the issues were fully litigated at that time. Id.

Merrell Dow recites a different standard to be employed when courts examine the collateral estoppel effect of a prior judgment on nonparties,4 ignoring the Supreme Court precedent pronounced in Montana and its progeny. Nonetheless, the Court must evaluate the appropriateness of the application of collateral estoppel to plaintiffs in this consolidated action using the Montana rule.

Plaintiffs in these cases had no direct financial or proprietary interest in the outcome of the MDL Common Issues Trial or in any subsequent individual Bendectin action against Merrell Dow. To the contrary, those plaintiffs who specifically opted out of the MDL Common Issues Trial withdrew precisely so that they would not be bound by its outcome. Upon their withdrawal, plaintiffs severed any financial interest they previously had in the outcome of that consolidated trial. See Lynch v. Merrell-National Laboratories, 830 F.2d 1190, 1193 (1st Cir.1987); see also In re Bendectin Cases, No. 85-0996, 1986 WL 20466 (E.D.Mich.1986). Plaintiffs' undeniable concern for a favorable outcome to the MDL Common Issues Trial or to other Bendectin trials does not constitute a financial or proprietary interest in the outcome. Mere academic interest in the determination of a question of law in a prior suit, or even a substantial interest in establishing favorable precedent under the doctrine of stare decisis, simply does not give rise to the presumption of financial or proprietary interest. Virginia Hosp. Ass'n, supra at 1313 quoting 1B J. Moore, J. Lucas, & T. Currier, Moore's Federal Practice ¶ 0.4116, at 446. Plaintiffs in this consolidated action had no financial stake in any previous Bendectin case and therefore cannot be estopped from litigating their claims on that basis.

The second inquiry, whether plaintiffs assumed control over any previous Bendectin lawsuit, dictates the same finding. Merrell Dow argues that plaintiffs in these cases participated in discovery in the MDL Common Issues Trial, rely on the same evidence presented in that action, and seek to prove the same contention litigated in that consolidated proceeding. This type of participation, however, does not amount to an exercise of control over the prior lawsuit. To have control over litigation, a party must have effective choice over which legal theories and proofs are advanced. Benson and Ford, Inc. v. Wanda Petroleum Co., 833 F.2d 1172, 1174 (5th Cir.1987). Examples of such control are: a president and sole shareholder controls his company; a parent corporation controls its subsidiary; and a liability insurer assumes control of the defense of the insured. Id. at 1174; Freeman v. Lester Coggins Trucking, Inc., 771 F.2d 860, 864 n. 3 (5th Cir.1985). It is simply not enough that a nonparty supplied an...

To continue reading

Request your trial
8 cases
  • Merrell Dow Pharmaceuticals, Inc. v. Havner
    • United States
    • Texas Supreme Court
    • November 13, 1997
    ...the evidence raised a fact question. Longmore v. Merrell Dow Pharms., Inc., 737 F.Supp. 1117 (D.Idaho 1990); In re Bendectin Prods. Liab. Litig., 732 F.Supp. 744 (E.D.Mich.1990); Hagen v. Richardson-Merrell, Inc., 697 F.Supp. 334 (N.D.Ill.1988); see also Lanzilotti v. Merrell Dow Pharms., I......
  • Paoli R.R. Yard PCB Litigation, In re
    • United States
    • U.S. Court of Appeals — Third Circuit
    • October 17, 1994
    ...studies in various contexts is mixed. 46 Many cases have held that the studies are admissible. See, e.g., In re Bendectin Prod. Liab. Litig., 732 F.Supp. 744, 749 (E.D.Mich.1990) (experts in the field think that it is reasonable to rely on non-epidemiological studies to link Bendectin to bi......
  • Conde v. Velsicol Chemical Corp.
    • United States
    • U.S. District Court — Southern District of Ohio
    • October 13, 1992
    ...when the Court is confronted with a "battle of the experts, the jury must decide the victor." In re Bendectin Products Liability Litigation, 732 F.Supp. 744, 748 (E.D.Mich. 1990) (citing Ferebee v. Chevron Chemical Co., 736 F.2d 1529, 1535 (D.C.Cir.), cert. denied, 469 U.S. 1062, 105 S.Ct. ......
  • In re Air Crash at Detroit Metropolitan Airport
    • United States
    • U.S. District Court — Western District of Michigan
    • October 4, 1991
    ...effect of federal diversity judgments); Cemer v. Marathon Oil Co., 583 F.2d 830, 831 (6th Cir.1978); In re Bendectin Products Liability Litigation, 732 F.Supp. 744, 746 (E.D.Mich.1990) (interpreting Cemer as holding that federal law governs inquiry of whether a prior federal court judgment ......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT